Impact of voriconazole plasma concentrations on treatment response in critically ill patients-Reference-Cited by-同舟云学术

Impact of voriconazole plasma concentrations on treatment response in critically ill patients

Published:2019-03-09 Issue:4 Volume:44 Page:572-578
ISSN:0269-4727
Container-title:Journal of Clinical Pharmacy and Therapeutics
language:en
Short-container-title:J Clin Pharm Ther

Author:

Ruiz Jesus¹,Gordon Mónica²,Villarreal Esther²,Peruccioni Marcela²,Marqués María Remedios³,Poveda-Andrés Jose Luis³,Castellanos-Ortega Álvaro²,Ramirez Paula²

Affiliation:

1. Intensive Care Unit; IIS La Fe. Hospital Universitari i Politècnic La Fe; Valencia Spain

2. Intensive Care Unit; Hospital Universitari i Politècnic La Fe; Valencia Spain

3. Pharmacy Department; Hospital Universitari i Politècnic La Fe; Valencia Spain

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/jcpt.12817/fullpdf

Reference40 articles.

1. Epidemiology of invasive aspergillosis in critically ill patients: clinical presentation, underlying conditions, and outcomes;Taccone;Crit Care Lond Engl,2015

2. Invasive aspergillosis in critically ill patients without malignancy;Meersseman;Am J Respir Crit Care Med,2004

3. Comparison of epidemiological, clinical, and biological features of invasive aspergillosis in neutropenic and nonneutropenic patients: a 6-year survey;Cornillet;Clin Infect Dis,2006

4. Disseminated aspergillosis in intensive care unit patients: an autopsy study;Dimopoulos;J Chemother Florence Italy,2003

5. Voriconazole: a new triazole antifungal agent;Johnson;Clin Infect Dis,2003

Cited by 27 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Voriconazole therapeutic drug monitoring including analysis of CYP2C19 phenotype in immunocompromised pediatric patients with invasive fungal infections;European Journal of Clinical Pharmacology;2024-09-06

2. Associated factors with voriconazole plasma concentration: a systematic review and meta-analysis;Frontiers in Pharmacology;2024-08-23

3. Optimized Antifungal Therapy for Chronic Pulmonary Aspergillosis;Medical Mycology Journal;2024-07-31

4. Isavuconazole Pharmacokinetics in Critically Ill Patients: Relationship with Clinical Effectiveness and Patient Safety;Antibiotics;2024-07-29

5. Renal Replacement Therapy as a New Indicator of Voriconazole Clearance in a Population Pharmacokinetic Analysis of Critically Ill Patients;Pharmaceuticals;2024-05-22